Drug Shortage Report for SOLU-CORTEF

Last updated on 2022-12-02 History
Report ID 173292
Drug Identification Number 00030619
Brand name SOLU-CORTEF
Common or Proper name SOLU-CORTEF
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) HYDROCORTISONE
Strength(s) 250MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 2mL vials
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-02
Estimated end date
Actual end date 2022-12-01
Shortage status Resolved
Updated date 2022-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-12-02 French Compare
v6 2022-12-02 English Compare
v5 2022-11-23 French Compare
v4 2022-11-23 English Compare
v3 2022-11-03 English Compare
v2 2022-11-02 French Compare
v1 2022-11-02 English Compare

Showing 1 to 7 of 7